This paper investigated the effects of needle gauge (G) on the concordance of Gleason scores between matched biopsy and resection prostate specimens and examined the effect of various patient characteristics on the discordance.
Prostate biopsy quality is independent of needle size: a randomized single-center prospective study.
Cicione A, Cantiello F, De Nunzio C, Tubaro A, Damiano R
Purpose
Conclusion
Gleason score concordance, concordance rates, and the risk to undergrade a biopsy were comparable for 16G and 18G biopsies. The rate of discordance between biopsy and resection was not associated with patient age, prostate volume, prostate specific antigen (PSA) level, PSA ratio, or needle gauge.
Studies (1)
Purpose
This study compared the concordance of Gleason scores of 16 and 18G needle biopsy specimens with matched resection specimens and examined the effect of patient characteristics (age, prostate volume, PSA level, and PSA ratio) on the discordance. One hundred and four patients scheduled for transrectal ultrasound-guided (TRUS) prostate biopsy were split randomly for biopsy using 16G and 18G needles (52 patients/group). Gleason scores obtained from biopsy specimens were compared with those obtained from the same patient after surgical resection.
Summary of Findings
Concordance of the Gleason scores between biopsy and resection specimens were comparable when the biopsy was performed with a 16G or 18G needle (κ=0.821 and 0.811, respectively). Further, the Gleason score concordance rates and risk to undergrade a biopsy were comparable between the needle types (76.9% and 21.1%, respectively for 16G and 75.6% and 15.4%, respectively for 18G). The rate of discordance between biopsy and resection was not associated with patient age, prostate volume, PSA level, PSA ratio, or needle gauge.
Biospecimens
TissueProstatePreservation Types
FormalinDiagnoses
NeoplasticCarcinomaPlatforms
MorphologyH-and-E microscopyMorphologyLight microscopyPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Patient age 44-82 yearsPreaquisition Prognostic factor 2.35-16.6 ng/mL PSA25-90 mL prostate volume3-35% PSABiospecimen Acquisition Method of tissue acquisition Core needle biopsySurgical resectionBiospecimen Acquisition Needle gauge 16G18G